United Therapeutics

UTHRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.111 B

$538.84 +1.11%

Close of 7 Aug 2026

Revenue

$3.18B

#887 by revenue

Earnings

$1.33B

#309 by earnings

Shares outstanding

42,890,692

Latest filing cover page

P/E ratio

17.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#21InsmedINSM$28.4B
#22Roivant SciencesROIV$26.3B
#23United TherapeuticsUTHR$23.1B
#24ViatrisVTRS$19.1B
#25Jazz PharmaceuticalsJAZZ$16.7B

Where these numbers come from

Share counts and financials for United Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.